Day: February 20, 2024

Chief Medical Officer Dr. Michael Chancellor will discuss hemorrhagic cystitis and the company’s lead candidate, LP-10 PITTSBURGH, Feb. 20, 2024 (GLOBE NEWSWIRE) — Lipella Pharmaceuticals Inc., (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a pioneering, clinical-stage pharmaceutical company, announced today that Chief Medical Officer Dr. Michael Chancellor will present at the PropThink Digital Investor Conference’s key opinion leader (KOL) discussion on Friday, February 23, 2024, at 2 PM ET. Dr. Chancellor’s presentation will be titled: “Urologist Talks Bladder Cancer and Lasting Side Effects”. PropThink is a leading online destination for investors seeking insights on publicly-traded, emerging growth companies in the healthcare sector.Webinar Information:     Date:   Friday,...

PLANT CITY, Fla., Feb. 20, 2024 (GLOBE NEWSWIRE) — Holiday Island Holdings, Inc., dba EP3OIL, (OTC: HIHI) – operating in the Secondary Recovery of Oil & Gas Industry – has accepted a Letter of Intent to enter into a Joint Venture wherein it will receive $2.5 million from a highly experienced international oil company – Supeca Oil –  to develop the Drummond Oil Field located in West Texas. Projections on this field, as reported by Benchmark Petroleum Partners, indicated a significant increase in gross revenue of oil production over its life. Glenn Klinker, CEO and Chairman of EP3OIL, says: “I am so happy with the confidence investors have instilled in EP3OIL and our ability to produce highly rewarding oil production.” Our recently appointed Vice President and Marketing Director for Latin America, Mr. Alverico Asencio,...

Figure 1.Map showing location of Northstar and Kaza claim groups in relation to existing copper ± gold prospects in north-central British Columbia.Figure 2.Compilation map of primary target on the Kaza Claims, showing geophysical anomalies in relation to geochemical sampling results and mapped geology.Figure 3.Map showing copper geochemistry and mapped geology at the area of historical exploration on the Northstar Claims.VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) — Prosper Gold Corp. (“Prosper Gold” or the “Company”) (TSXV:PGX) is pleased to announce that the Company has entered into a definitive option agreement (the “Option Agreement”) with several individuals (collectively, the “Optionors”), whereby the Optionors have granted the Company the option to acquire a 100% interest (the “Option”)...

MARIETTA, Ga., Feb. 20, 2024 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that senior management will participate in the TD Cowen 44th Annual Health Care Conference. TD Cowen | Boston, MA | March 4-6, 2024Presentation: Monday, March 4, 2024 at 2:10 PM ETWebcast: Click here to access Institutional investors interested in meeting with senior management may contact their TD Cowen representative. A live webcast of the presentation will be available on the Events page of the Investors section of the Company’s website at www.mimedx.com or through the conference site by using the link above. A replay will be available on the Company’s website following the event. About MIMEDXMIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage...

CUPERTINO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the 2024 BIO CEO & Investor Conference, taking place February 26-27, 2024, in New York, NY.2024 BIO CEO & Investor Conference  Format: Presentation and one-on-one investor meetingsDate: Monday, February 26, 2023 Time: 2:45 p.m. ETLocation: New York, NYTo register for the conference and schedule a one-on-one meeting with Reviva management, please use the link HERE. About Reviva Reviva is a late-stage...

The highly integrated 3.3 kV XIFM plug-and-play digital gate driver is designed to work out-of-the-box with high-voltage SiC-based power modules to simplify and speed system integration CHANDLER, Ariz., Feb. 20, 2024 (GLOBE NEWSWIRE) — The electrification of everything is driving the widespread adoption of Silicon Carbide (SiC) technology in medium-to-high-voltage applications like transportation, electric grids and heavy-duty vehicles. To help developers implement SiC solutions and fast-track the development process, Microchip Technology (Nasdaq: MCHP) today introduces the 3.3 kV XIFM plug-and-play mSiC™ gate driver with patented Augmented Switching™ technology, which is designed to work out-of-the-box with preconfigured module settings to significantly reduce design and evaluation time. To speed time to market,...

– Fast Track designation has the potential to accelerate lead asset IMM-1-104’s path to U.S. FDA submission for pancreatic ductal adenocarcinoma – – Company expects multiple readouts from its Phase 1/2a clinical trial in 2024 – CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for its lead clinical-stage program, IMM-1-104, for the treatment of patients with pancreatic ductal adenocarcinoma (PDAC) who have failed one line of treatment. IMM-1-104 is designed to provide universal-RAS activity through deep cyclic inhibition of the MAPK pathway with once-daily...

EL SEGUNDO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — Big 5 Sporting Goods Corporation (Nasdaq: BGFV) (the “Company”), a leading sporting goods retailer, will announce fourth quarter and full year fiscal 2023 financial results on Tuesday, February 27, 2024, after the market close. The Company will host a conference call to discuss these results and provide additional comments and details. The conference call is scheduled to begin at 2:00 p.m. Pacific Time on Tuesday, February 27, 2024. To access the conference call, participants in North America may dial (877) 407-9039 and international participants may dial (201) 689-8470. Participants are encouraged to dial in to the conference call ten minutes prior to the scheduled start time. In addition, the call will be broadcast live over the Internet and accessible through the Company’s...

DALLAS, Feb. 20, 2024 (GLOBE NEWSWIRE) — DZS (Nasdaq: DZSI), a global leader of access, optical and AI-driven cloud software solutions, today announced that Todd Jackson and Paul Choi have been appointed to the company’s Board of Directors. Jackson and Choi join the DZS Board following three strategic transactions: securing $25 million of working capital through two transactions, a private placement of DZS common stock and a term loan; the planned divestiture of the company’s lower margin Asia business, which, upon closing, will eliminate $43 million of debt; and an additional $5 million of working capital. The sale of the Asia business is expected to close in the first quarter of 2024. Jackson is an accomplished attorney who brings to the DZS Board 30 years of M&A advisory and transaction experience with over $30 billion...

BASKING RIDGE, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, Ph.D., President and Chief Executive Officer of Lisata, will present at the BIO CEO & Investor Conference being held on February 26-27, 2024 at the New York Marriott Marquis in New York City. Dr. Mazzo’s presentation is on Monday, February 26, 2024 at 11:15 a.m. Eastern time. Management will also be available for in-person one-on-one meetings with investors. For those interested in meeting with management during the conference, please request a meeting through the online conference platform or reach out to John Menditto, VP...